Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
H Liu
Observed name:
Hui Liu
Institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
Observed institutions:
Second Affiliated Hospital of Zhejiang University,
Zhejiang University
ORCID:
0000-0003-1452-5062
Observed ORCID:
0000-0003-1452-5062
OpenAlex ID:
A5007531035
Multicenter Real‐World Analysis of Glofitamab in Relapsed/Refractory Primary CNS Lymphoma: Clinical Activity, CNS Penetration, and ctDNA Dynamics
2026
·
Apeng Yang
, Jinfeng Dong
, et al.
·
American Journal of Hematology
·
4
[Efficacy and safety of fourth-generation CD19 CAR-T expressing IL7 and CCL19 along with PD-1 monoclonal antibody for relapsed or refractory large B-cell lymphoma].
2023
·
T Yu
, H Liu
, et al.
·
PubMed Central
·
2
PDF
[How I manage B cell lymphoma patients treated with CD19 specific CAR-T cell throughout whole-process management].
2022
·
W B Qian
, H Liu
·
PubMed Central
·
1
PDF
Show more works
View as search
Works count:
3
Citation count:
7
H-index:
2
I10-index:
Year
Topic
Type